Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets.
Bespalov A, Steckler T, Altevogt B, Koustova E, Skolnick P, Deaver D, Millan MJ, Bastlund JF, Doller D, Witkin J, Moser P, O'Donnell P, Ebert U, Geyer MA, Prinssen E, Ballard T, Macleod M.
Bespalov A, et al. Among authors: steckler t.
Nat Rev Drug Discov. 2016 Jul;15(7):516. doi: 10.1038/nrd.2016.88. Epub 2016 Jun 17.
Nat Rev Drug Discov. 2016.
PMID: 27312728
No abstract available.